Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sesamin is a naturally occurring lignan compound found predominantly in sesame seeds and sesame oil. It is widely used as a dietary supplement due to its antioxidant, anti-inflammatory, and lipid-lowering properties. Mechanistically, sesamin acts as a fatty acid metabolism modifier by inhibiting delta-5-desaturase (Δ5-desaturase), an enzyme involved in polyunsaturated fatty acid biosynthesis, leading to reduced levels of eicosapentaenoic acid (EPA) and arachidonic acid. Sesamin also inhibits tocopherol-ω-hydroxylation, the rate-limiting step in vitamin E metabolism, resulting in increased levels of γ-tocopherol and γ-tocotrienol. Additionally, it modulates drug-metabolizing enzymes by acting as an inhibitor of cytochrome P450 3A4 (CYP3A4) through antagonism of the pregnane X receptor (PXR), potentially affecting drug interactions[1][2][5]. Sesamin has demonstrated anti-cancer effects via suppression of NF-κB activation pathways and modulation of estrogen receptor activity[6][7]. It is not developed or marketed by any specific pharmaceutical company but is available as a nutritional supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sesamin.